1.27
Katherine Unger Baillie
Science News Officer
kbaillie@upenn.edu
Cancer Research
Lab-grown brain organoids, rapidly deployed, can fight glioblastomas
Lab-grown brain organoids, rapidly deployed, can fight glioblastomas
Glioblastoma organoids grown from patients’ own glioblastoma tissue can be used to investigate personalized treatment approaches in time-sensitive cases.
An entire course of radiation treatment in under one second
An entire course of radiation treatment in under one second
Findings related to FLASH radiotherapy—using protons rather than electrons—prove feasible in the future for cancer therapy.
Proton therapy lowers risk of side effects in cancer patients
Proton therapy lowers risk of side effects in cancer patients
Proton therapy leads to a significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation. Cure rates between the two groups are almost identical.
Using radiomics to predict breast cancer
Using radiomics to predict breast cancer
Penn researchers can predict 10-year breast cancer recurrence with MRI scans that characterize the genetic makeup of tumors, allowing for individualized, non-invasive treatment.
Promising findings for multiple myeloma immunotherapy
Promising findings for multiple myeloma immunotherapy
Adam Cohen of the Perelman School of Medicine headed a clinical trial that found an experimental therapy can make a difference for patients who have exhausted other options.
Engineering the immune system to tackle glioblastoma
Engineering the immune system to tackle glioblastoma
Immunotherapy is a “game changer” for improving outcomes in treating Glioblastoma Multiforme, the most common, and most lethal, malignant brain tumor in adults.
A new role for a triple-negative breast cancer target
A new role for a triple-negative breast cancer target
A team led by Rumela Chakrabarti of the School of Veterinary Medicine has made new discoveries into how a key protein involved in triple-negative breast cancer functions in puberty.
Off-the-shelf immunotherapy can bring lymphoma patients closer to remission
Off-the-shelf immunotherapy can bring lymphoma patients closer to remission
A Penn study shows the promise of an off-the-shelf immunotherapy in relapse/refractory non-Hodgkin lymphoma, even when CAR T therapy fails.
The new tool in fighting cancer: Antibiotics
The new tool in fighting cancer: Antibiotics
The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy.
Researchers identify method to slow down cancer cells efforts to multiply
Researchers identify method to slow down cancer cells efforts to multiply
A study from the Abramson Cancer Center finds that turning on a key metabolic process could make soft tissue sarcoma more susceptible to treatment.
Media Contact
Experts
In the News
HealthDay News
For Breast Cancer Patients, Less Time on Hormonal Meds?
Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.
FULL STORY →
Nature
Acupuncture in Cancer Study Reignites Debate About Controversial Technique
Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.
FULL STORY →